2023 Highlights and 2024 Projections by Steve Gens, Managing Partner
Via Gens & Associates
Affiliates Want a Substantially Increased Role in Transforming Global RIM, Finds a Major New Global Study
Via International Pharmaceutical Industry
Life Science Local Affiliates are Key to more Consistent and Effective Global Regulatory Processes
Via The Journal of mHealth
Data Governance: Tackling Complexity with Baby Steps
Via Innovations in Pharmaceutical Technology
Beyond Modernisation – Unlocking the Value of Regulatory Information Management
Via Journal for Clinical Studies
Dispelling 4 Common Myths Of Data Quality Governance
Via Outsourced Pharma
Challenge of Our Age
Via PharmaTimes
Opening Up Opportunities in 2023
Via Pharmaceutical Technology
Transforming RIM – Connecting the Enterprise, the Patient and the Market to More Timely Regulatory Information
Via Pharmaceutical Outsourcing
Driving Value From Investment In RIM Digitisation
Via European Pharmaceutical Contractor
RIM Investment Shifts Focus to Cross-functional Data Sharing and Intelligent Tools
Via the Journal of mHealth
The Next Steps for Biopharma Regulations
Via Drug Discovery World
After a Decade of Regulatory Transformation, What’s Next?
Via Pharmaceutical Commerce
Life Sciences RIM: Modernization & Moving Ahead
Via Pharmaceutical Online
Gens & Associates Announce Premier Benchmark Membership Program
Via Gens & Associates